ϟ
 
DOI: 10.1136/thx.2009.133504
¤ OpenAccess: Bronze
This work has “Bronze” OA status. This means it is free to read on the publisher landing page, but without any identifiable license.

Chemotherapy should not be withheld from patients with an indwelling pleural catheter for malignant pleural effusion

A. Morel,Eleanor Mishra,Louise Medley,Najib M. Rahman,John Wrightson,Denis Talbot,Robert J. O. Davies

Medicine
Malignant pleural effusion
Pleural effusion
2010
presence of procoagulant factors (macrophages and activated leucocytes are known to increase activation of thrombin and fibrin formation) and co-existence of sarcoidosis and antiphospholipid syndrome. 5Antiphospholipid antibodies occur in 2e5% of the general population, but in up to 38% patients with sarcoidosis, correlating with poorer prognosis. 5verall, our findings would be viewed as hypothesis generating, providing a platform for further study, and supportive of the anecdotal observations made in our Sarcoidosis Clinic.Despite the limitations discussed above, PE should be considered in patients with sarcoidosis when there is sudden deterioration in dyspnoea.
Loading...
    Cite this:
Generate Citation
Powered by Citationsy*
    Chemotherapy should not be withheld from patients with an indwelling pleural catheter for malignant pleural effusion” is a paper by A. Morel Eleanor Mishra Louise Medley Najib M. Rahman John Wrightson Denis Talbot Robert J. O. Davies published in 2010. It has an Open Access status of “bronze”. You can read and download a PDF Full Text of this paper here.